ROFACT
Identification of Rofact
| No description |
Google image searchProduct monograph
Active ingredient
rifampin, 150 MG
DIN: 00393444
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 02-JUL-2019
ATC:
- J04 — ANTIMYCOBACTERIALS (ATC, ATC/DDD, )
- J04A — DRUGS FOR TREATMENT OF TUBERCULOSIS (ATC, ATC/DDD)
- J04AB — Antibiotics (ATC, ATC/DDD)
- J04AB02 — RIFAMPICIN (ATC/DDD)
Reference brand drug: Rofact
Pharmaceutical standard: USP
